Please login to the form below
urinary tract symptoms
This page shows the latest urinary tract symptoms news and features for those working in and with pharma, biotech and healthcare.
MS and cholesterol drugs picked for new UK rapid uptake push
Urolift for lower urinary tract symptoms of benign prostatic hyperplasia. The list is made up of seven ‘high-potential products’ with a strong evidence base that are already available to the
Latest news
-
Astellas gets first OK for prostate drug Vesomni
Approved in the Netherlands to treat men with lower urinary tract symptoms. ... BPH). Approval in the Netherlands as a treatment for lower urinary tract symptoms (LUTS) in men with BPH who are not responding to current therapy kicks off the mutual
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Hayward Medical Communications continues partnership with Prostate Cancer UK
As community pharmacy is often the first point-of-call for men experiencing urinary tract symptoms, Hayward worked with Prostate Cancer UK to develop an e-learning programme specifically created for ... The materials developed allow men to identify the
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- BMS eyes approval for second Opdivo combo in kidney cancer
- FDA hands BMS and bluebird bio a priority review for ide-cel
- 20 for 2020 – Five pharma companies to watch
- Using Artificial Intelligence to Transform Pharma
- Session 4: Systems Innovation Insight and Thinking
- Transforming Unstructured Healthcare Information into Real-World Evidence & Life Saving Insights
- UK COVID-19 vaccine ‘challenge trials’ could intentionally infect participants with virus
- Keytruda doubles five-year survival rate in NSCLC
- EMA fast-tracks review of bluebird bio’s LentiGlobin for sickle cell disease
PMHub
Attigo (part of the Mednet Group)
Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...
Latest intelligence
- Surviving cancer: a new era for patients
- Now more than ever, a shift in perspective is needed...
- Crisis? No problem!
- Issues planning & management for pharma spokespeople, by Andrew Smith...
- Are patient recruitment and retention rates rising or falling?
- First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Quick links
Infographics
